Press Release

Dec, 19 2022

Siemens Healthcare Private Limited (a Subsidiary of Siemens), Radiometer India (a Subsidiary of Danaher), and F. Hoffmann-La Roche Ltd. are expected to dominate the India Blood Gas Analyzer Market in 2022

India Blood Gas Analyzer Market is expected to grow with a CAGR of 7.1% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/india-blood-gas-analyzer-market

India blood gas analyzer market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to a favorable market scenario.   

The major players dealing in the India blood gas analyzer market are introducing a strong range of products provider along with launching new services and adopting strategic initiatives such as acquisition, agreement, business expansion, awards, and recognition into the market. This helped companies to maximize sales with an enhanced service portfolio.

For instances,

  • In May 2019, Radiometer won the Red Dots Design Awards for analyzer - ABL9 blood gas analyzer in the field of design and innovation
  • In May 2022, F. Hoffmann-La Roche Ltd. announced that it partnered with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure. This partnership helps the organization in developing a market image

Siemens Healthcare Private Limited (a Subsidiary of Siemens) is the dominating player in the India blood gas analyzer market. The other key players existing in the market include Abbott, Techno MedicaCo., Ltd., Nova Biomedical, WERFEN, Sensacore, OPTI Medical Systems, HDC India, AFFORD MEDICAL TECHNOLOGIES PVT. LTD., Radiometer India (a Subsidiary of Danaher), F. Hoffmann-La Roche Ltd., i-SENS, Inc., EDAN Instruments, Inc., ESCHWEILER GmbH & CO.KG, essential medical, Medica Corporation, and Wondfo among others.

Siemens Healthcare Private Limited (a Subsidiary of Siemens)

Siemens Healthcare Private Limited (a Subsidiary of Siemens) is headquartered in Munich, Germany, and was founded in 1896. The company focuses on extending the accuracy medication, changing consideration conveyance, and working on quiet insight, all empowered by digitalizing medical services. The company offers various products such as medical imaging, laboratory diagnostics, point of care testing, services, clinical specialties & disease, and healthcare IT, where point of care testing is the market-focused category.

The company has various subsidiaries that are Siemens Healthineers AG (Germany), Kyros 65 GmbH, (Germany), Aimsun Pty Ltd(Australia), Siemens Ltd. (China), and Acrorad Co., Ltd. (Japan), among others.

The company has a presence in North America, South America, Europe, and Asia-Pacific.

Radiometer India (a Subsidiary of Danaher)

Radiometer India is headquartered in Mumbai, India, and was founded in 1935. The company focuses on providing acute care diagnostic solutions to healthcare professionals and hospitals. The company offers various products in the following product categories blood gas testing, transcutaneous monitoring, immunoassay testing, 1st automatic, AQURE POC IT solution, live connect digital service, arterial blood gas samplers, diabetes, and hematology, where blood gas testing and arterial blood gas samplers is the market-focused category.

The company has a presence in Asia-Pacific, Europe, North America, and Middle East and Africa.

India Blood Gas Analyzer Market

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is headquartered is in Basel, Switzerland, and was founded in 1896. The company focuses on pioneering therapies to prevent vision loss, working to discover and develop innovative solutions, and aiming to redefine standards of care. The company operates business segments such as pharmaceuticals and Roche diagnostics, where Roche diagnostics is market focused segment. The company offers products product such as core lab, molecular lab, point of care, diabetes care, pathology lab, neuroscience, oncology, and immunology, where which point of care is the market-focused category.

The company has various subsidiaries that are Roche Diabetes Care Argentina S.A. (Argentina), Roche Diagnostic Brasil Ltd. (Brazil), Roche Austria GmbH (Austria), Roche Algerie SPA (Algeria), Roche Bangladesh Limited (Bangladesh), and Roche Products Pty Limited (Australia), among others.

The company has a presence in North America, Europe, Asia-Pacific, and Middle East and Africa.


Client Testimonials